Trials / Terminated
TerminatedNCT02775656
UCB Cimzia Pregnancy Follow-up Study
An Observational Follow-up Study of Women Who Become Pregnant While Participating in a Certolizumab Pegol (CZP) Clinical Study or Whose Pregnancies Have Otherwise Been Reported to UCB Due to Potential CZP Exposure During Pregnancy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- UCB BIOSCIENCES, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnancy.
Conditions
- Rheumatoid Arthritis (RA)
- Crohn's Disease (CD)
- Psoriatic Arthritis (PsA)
- Axial Spondyloarthritis and Ankylosing Spondylitis
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-05-17
- Last updated
- 2021-04-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02775656. Inclusion in this directory is not an endorsement.